Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Menopause Knowledge Level and Myth Beliefs (Menopause)

28 mai 2026 mis à jour par: Abdurrahim UYANIK, Tokat Gaziosmanpasa University

The Effect of Pecha Kucha and Traditional Education on Menopause Knowledge Level and Myth Beliefs: Randomized Controlled Trial

This study aims to compare the effects of the Pecha Kucha and PowerPoint presentation methods on menopause knowledge and beliefs in menopause-related myths. By introducing an innovative, concise, focused, and visually based approach to menopause education, this research is expected to strengthen health literacy, reduce myths, and contribute to the development of more positive attitudes toward menopause among women. Furthermore, by evaluating both menopause myths and different educational techniques together, this study is anticipated to be the first in the literature and to serve as a reference for future research.

Research questions:

  1. Does menopause-related knowledge increase among women who receive education using the Pecha Kucha technique and the PowerPoint method?
  2. Do beliefs in menopause-related myths decrease among women who receive education using the Pecha Kucha technique and the PowerPoint method?
  3. Is there a difference between the Pecha Kucha technique and the PowerPoint method in terms of women's menopause-related knowledge levels and their beliefs in menopause-related myths?

Aperçu de l'étude

Description détaillée

Study Type

This study is designed as a randomized controlled trial.

Aim of the Study

This study aims to compare the effects of traditional PowerPoint and Pecha Kucha presentation methods on menopause knowledge and awareness of menopause myths among women in Türkiye.

Study Population and Sample

The study will be conducted online across Türkiye. Participants will be recruited via an Instagram announcement, and educational sessions will be delivered through Google Meet. Women who voluntarily apply through the online registration form and meet the eligibility criteria will be included.

Sample size was calculated using G*Power version 3.1.9.3. Since no similar study examining the effects of PowerPoint and Pecha Kucha presentation methods on menopause knowledge and awareness of menopause myths was identified in the literature, a large effect size was assumed (Cohen's d = 0.70) (Cohen, 1992). Based on a significance level of α = 0.05 and statistical power of 80% (1-β = 0.80), the minimum sample size was calculated as 72 participants, with 36 participants allocated to each group.

Randomization and Blinding

Eligible participants will be assigned independent identification codes by a researcher not involved in data analysis. Randomization will be performed using the "List Randomizer" tool on Random.org with a 1:1 allocation ratio. Participants will be randomly assigned to either the Pecha Kucha (P-K) group or the PowerPoint (PPT) group.

Participants will be informed that a menopause-related educational study is being conducted but will not be informed about the Pecha Kucha method before allocation. Outcome data will be analyzed by an independent statistician blinded to group assignments.

Intervention Pecha Kucha Group (P-K)

Participants in the P-K group will receive menopause education through the Pecha Kucha presentation format consisting of 20 slides displayed for 20 seconds each (total duration: 6 minutes and 40 seconds). The presentation will include highly visual materials with minimal text.

PowerPoint Group (PPT)

Participants in the PPT group will receive the same educational content using a traditional PowerPoint presentation format. The session will consist of approximately 30 slides and last 30-35 minutes.

Both groups will be trained by the same educator in separate online sessions. Educational content will include:

Definition and physiology of menopause Hormonal changes during menopause Vasomotor, urogenital, and psychosocial symptoms Common menopause myths and misconceptions Effects of myths on women's health and quality of life Evidence-based menopause information Healthy lifestyle behaviors during menopause Data Collection Procedure

Online questionnaires will be completed immediately before and after the educational intervention. Data collection will be conducted via Google Meet in a single-session format, and completion of the forms will require approximately 10-15 minutes.

Statistical Analysis

Data will be analyzed using IBM SPSS Statistics version 25.0. Descriptive statistics will be presented as frequencies, percentages, mean, and standard deviation. Normality will be assessed using the Kolmogorov-Smirnov test. Within-group pretest-posttest comparisons will be analyzed using paired samples t-tests, while between-group differences will be assessed using independent samples t-tests. Non-parametric equivalents (Wilcoxon signed-rank test and Mann-Whitney U test) will be used for non-normally distributed data. Statistical significance will be accepted at p < 0.05.

Ethical Considerations

Ethical approval will be obtained from the Tokat Gaziosmanpaşa University Human Research Ethics Committee. Written and verbal informed consent will be obtained from all participants prior to data collection. Participant confidentiality will be maintained, and personal data will be used solely for research purposes. Participants may withdraw from the study at any stage without penalty. The study will be conducted in accordance with the principles of the Declaration of Helsinki.

Type d'étude

Interventionnel

Inscription (Réel)

500

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Tokat Province
      • Erbaa, Tokat Province, Turquie (Türkiye), 60500
        • Tokat Gaziosmanpasa University

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Oui

La description

Inclusion Criteria:

  • Being between 30 and 65 years of age (the lower age limit of 30 years was determined to establish a methodological threshold between young adulthood, in which menopause perception has not yet developed, and the menopausal transition period)
  • Being female
  • Volunteering to participate in the study
  • Not having previously received education about menopause
  • Being able to use technological devices
  • Being able to understand Turkish

Exclusion Criteria:

  • Being outside the 30-65 age range
  • Having a history of prior menopause-related education or formal training
  • Having cognitive, psychiatric, or medical conditions that could impair the ability to understand and complete the study procedures or questionnaires

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Recherche sur les services de santé
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Pecha Kucha
A presentation consisting of 20 slides, supported by high-resolution visual materials and lasting 6 minutes and 40 seconds, was delivered. Each slide was displayed for 20 seconds as planned. The training included fundamental information about the menopausal period and addressed commonly encountered myths and misconceptions.
A presentation consisting of 20 slides, supported by high-resolution visual materials and lasting 6 minutes and 40 seconds, was delivered. Each slide was displayed for 20 seconds as planned. The training included fundamental information about the menopausal period and addressed commonly encountered myths and misconceptions
Comparateur actif: PowerPoint group
Participants in this group received education on menopause and menopause-related myths using the PowerPoint presentation method. The same content was delivered by the same educator using the PowerPoint format. The presentation consisted of 30 slides and lasted approximately 35 minutes.
Participants in this group received education on menopause and menopause-related myths using the PowerPoint presentation method. The same content was delivered by the same educator using the PowerPoint format. The presentation consisted of 30 slides and lasted approximately 35 minutes.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Menopause Knowledge
Délai: 1 hour
Menopause Knowledge Scale The scale developed by Mete et al. (2024) is a 5-point Likert-type scale. The items of the Menopause Knowledge Scale can be summed, and an increase in the score indicates increased knowledge of menopause. A minimum total score of 14 and a maximum total score of 70 can be obtained from the scale. Knowledge of Menopause Symptoms and Management (Factor 1) consists of questions 6, 7, 8, 9, 10, 11, 12, 13, and 14, with a minimum score of 9 and a maximum score of 45. General Menopause Knowledge (Factor 2) consists of questions 1, 2, 3, 4, and 5, with a minimum score of 5 and a maximum score of 25. The internal consistency Cronbach's alpha reliability coefficient of the scale is 0.917, 0.830 for Factor 1, and 0.908 for Factor 2.
1 hour

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Menopause Myths
Délai: 1 hour
Menopause Myths Scale The Menopause Myths Scale (MMS), developed by Erol and Beydağ (2025), is a 5-point Likert-type scale designed to assess misconceptions about the menopausal process. The scale consists of 13 items and three sub-dimensions. The sub-dimensions are: "Myths regarding the impact on sexual life" (items 1-6), "Myths regarding the impact on family and social life" (items 7-10), and "Myths regarding the impact on mental health" (items 11-13). In the study where the scale was developed, the Cronbach's alpha coefficient was determined as 0.87; it was reported as 0.85 for the sub-dimensions "Myths regarding the impact on sexual life", and 0.79 for "Myths regarding the impact on family and social life" and "Myths regarding the impact on mental health". The maximum score that can be obtained from the scale is 65. The minimum score is 13. It is stated that as the score increases, the belief in myths also increases.
1 hour

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

15 février 2026

Achèvement primaire (Réel)

16 février 2026

Achèvement de l'étude (Réel)

20 février 2026

Dates d'inscription aux études

Première soumission

22 mai 2026

Première soumission répondant aux critères de contrôle qualité

28 mai 2026

Première publication (Réel)

3 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

3 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

28 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • Gaziosmanpasa- AUGE

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner